1. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
- Author
-
Ierardi AM, Carnevale A, Rossi UG, Renzulli M, Garanzini E, Golfieri R, Macchione N, Cittanti C, Giganti M, and Carrafiello G
- Subjects
- Aged, Aged, 80 and over, Carcinoma, Renal Cell diagnostic imaging, Carcinoma, Renal Cell pathology, Feasibility Studies, Female, Humans, Kidney Neoplasms pathology, Male, Prospective Studies, Retroperitoneal Neoplasms diagnostic imaging, Retroperitoneal Neoplasms pathology, Surgery, Computer-Assisted, Tomography, X-Ray Computed, Treatment Outcome, Carcinoma, Renal Cell surgery, Catheter Ablation methods, Kidney Neoplasms surgery, Microwaves therapeutic use, Neoplasm Recurrence, Local, Nephrectomy, Retroperitoneal Neoplasms surgery
- Abstract
Renal cell carcinoma (RCC) local recurrence after radical nephrectomy is uncommon. When feasible, surgical removal remains the primary treatment strategy; nevertheless, local RCC relapse management is controversial, and less invasive procedures may represent an attractive option to achieve oncologic control. The aim of our study was to assess the feasibility, safety, and clinical outcomes of image-guided percutaneous microwave ablation (MWA) for RCC local recurrence in patients initially treated with nephrectomy with curative intent. 10 consecutive patients underwent CT-guided percutaneous MWA of a total of 10 retroperitoneal nodules. Inclusion criteria were: histologically verified retroperitoneal metastases, previous radical nephrectomy, lesion no larger than 3 cm, no other metastatic site elsewhere. All the procedures were performed under moderate sedation choosing the most favorable patient decubitus. If deemed necessary, pneumodissection was induced before ablation. After the antenna placement inside the target lesion, thermal ablation was achieved by maintenance of a power of 100 W for a total time between 2 and 4 min. All patients were observed overnight and discharged the following day if clinically stable. Technical success was obtained in 100% of patients. One patient was re-treated to complete oncologic response with repeat MWA. No major complications were observed. No patients demonstrated local recurrence at a mean follow-up of 26 months. MWA is a safe and effective treatment strategy for loco-regional relapse of RCC following radical nephrectomy. This technique may represent a valuable approach for patients who are not eligible for surgery.
- Published
- 2020
- Full Text
- View/download PDF